Supplementary Table S1 from The Spectrum of IDH- and H3-Wildtype High-Grade Glioma Subgroups Occurring across Teenage and Young Adult Patient Populations

Supplementary Table S1 from The Spectrum of IDH- and H3-Wildtype High-Grade Glioma Subgroups Occurring across Teenage and Young Adult Patient Populations

<p>Supplementary Table 1 Sample cohort. Clinicopathological and molecular profiling data of the TYA HGG cohort (n=207).</p>

Saved in:

書目詳細資料
主要作者:	Rita Pereira (21902867) (author)
其他作者:	Alan Mackay (21902870) (author), Yura Grabovska (21902873) (author), Amelia Bradley (21902876) (author), Tabitha Bloom (21902879) (author), James Nicoll (21902882) (author), Delphine Boche (21902885) (author), John Procter (21902888) (author), Mellissa Maybury (19801010) (author), Johanna Schagen (21902891) (author), Liam Walker (21902894) (author), Federico Roncaroli (21902897) (author), Konstantina Karabatsou (21902900) (author), Olumide Ogunbiyi (16015990) (author), Thijs van Dalen (21902903) (author), Jai Sidpra (21902906) (author), Sabrina Rossi (18716353) (author), Evelina Miele (15110894) (author), David S. Ziegler (11404467) (author), Zhifeng Shi (21902909) (author), Thomas S. Jacques (15117937) (author), Darren Hargrave (15016889) (author), Bassel Zebian (21902912) (author), Cristina Bleil (21902915) (author), Joseph Yates (21902918) (author), Emma Norton (21902921) (author), Henry Mandeville (21902924) (author), Antonia Creak (21902927) (author), Liam Welsh (21902930) (author), Lynley Marshall (21902933) (author), Fernando Carceller (14945229) (author), Sucheta J. Vaidya (21902936) (author), Zita Reisz (21902939) (author), Safa Al-Sarraj (21902942) (author), Angela Mastronuzzi (18716362) (author), Andrea Carai (18716350) (author), Maria Vinci (15121544) (author), Kathreena M. Kurian (14953137) (author), Ho-keung Ng (21902945) (author), Sebastian Brandner (15115181) (author), Chris Jones (20656955) (author), Matthew Clarke (20656949) (author)
出版:	2025
主題:	Cancer Cancer Risk Factors Molecular and Cellular Biology Therapeutic Research and Development Clinical Research and Trials CNS Cancers Gliomas, Glioblastomas Epigenetics DNA methylation Precision Medicine Rare Cancers Translational Research
標簽:	添加標簽沒有標簽, 成為第一個標記此記錄!

相似書籍

Supplementary Table S2 from The Spectrum of IDH- and H3-Wildtype High-Grade Glioma Subgroups Occurring across Teenage and Young Adult Patient Populations
由: Rita Pereira (21902867)
出版: (2025)

Supplementary Table S3 from The Spectrum of IDH- and H3-Wildtype High-Grade Glioma Subgroups Occurring across Teenage and Young Adult Patient Populations
由: Rita Pereira (21902867)
出版: (2025)

Supplementary Table S4 from The Spectrum of IDH- and H3-Wildtype High-Grade Glioma Subgroups Occurring across Teenage and Young Adult Patient Populations
由: Rita Pereira (21902867)
出版: (2025)

Supplementary Data 1 from Liquid Biopsy of Cerebrospinal Fluid Enables Selective Profiling of Glioma Molecular Subtypes at First Clinical Presentation
由: Francesca Orzan (15055579)
出版: (2025)

Supplementary Data 2 from Liquid Biopsy of Cerebrospinal Fluid Enables Selective Profiling of Glioma Molecular Subtypes at First Clinical Presentation
由: Francesca Orzan (15055579)
出版: (2025)

Supplementary Data 3 from Liquid Biopsy of Cerebrospinal Fluid Enables Selective Profiling of Glioma Molecular Subtypes at First Clinical Presentation
由: Francesca Orzan (15055579)
出版: (2025)

Figure 1 from Repurposing Vandetanib plus Everolimus for the Treatment of <i>ACVR1</i>-Mutant Diffuse Intrinsic Pontine Glioma
由: Diana M. Carvalho (5608127)
出版: (2025)

Figure 2 from Repurposing Vandetanib plus Everolimus for the Treatment of <i>ACVR1</i>-Mutant Diffuse Intrinsic Pontine Glioma
由: Diana M. Carvalho (5608127)
出版: (2025)

Figure 3 from Repurposing Vandetanib plus Everolimus for the Treatment of <i>ACVR1</i>-Mutant Diffuse Intrinsic Pontine Glioma
由: Diana M. Carvalho (5608127)
出版: (2025)

Figure 4 from Repurposing Vandetanib plus Everolimus for the Treatment of <i>ACVR1</i>-Mutant Diffuse Intrinsic Pontine Glioma
由: Diana M. Carvalho (5608127)
出版: (2025)

Figure 5 from Repurposing Vandetanib plus Everolimus for the Treatment of <i>ACVR1</i>-Mutant Diffuse Intrinsic Pontine Glioma
由: Diana M. Carvalho (5608127)
出版: (2025)

Table 1 from Repurposing Vandetanib plus Everolimus for the Treatment of <i>ACVR1</i>-Mutant Diffuse Intrinsic Pontine Glioma
由: Diana M. Carvalho (5608127)
出版: (2025)

Table 2 from Repurposing Vandetanib plus Everolimus for the Treatment of <i>ACVR1</i>-Mutant Diffuse Intrinsic Pontine Glioma
由: Diana M. Carvalho (5608127)
出版: (2025)

Supplementary Table S1 from PGC1α Degradation Suppresses Mitochondrial Biogenesis to Confer Radiation Resistance in Glioma
由: Mengjie Zhao (14845174)
出版: (2025)

Supplementary Table S2 from PGC1α Degradation Suppresses Mitochondrial Biogenesis to Confer Radiation Resistance in Glioma
由: Mengjie Zhao (14845174)
出版: (2025)

Supplementary Table S4 from PGC1α Degradation Suppresses Mitochondrial Biogenesis to Confer Radiation Resistance in Glioma
由: Mengjie Zhao (14845174)
出版: (2025)

Supplementary Table S5 from PGC1α Degradation Suppresses Mitochondrial Biogenesis to Confer Radiation Resistance in Glioma
由: Mengjie Zhao (14845174)
出版: (2025)

Supplementary Table S8 from PGC1α Degradation Suppresses Mitochondrial Biogenesis to Confer Radiation Resistance in Glioma
由: Mengjie Zhao (14845174)
出版: (2025)

Supplementary Figure S1 from A Sequential Targeting Strategy Interrupts AKT-Driven Subclone-Mediated Progression in Glioblastoma
由: Sied Kebir (15048732)
出版: (2025)

Supplementary Figure S2 from A Sequential Targeting Strategy Interrupts AKT-Driven Subclone-Mediated Progression in Glioblastoma
由: Sied Kebir (15048732)
出版: (2025)

Supplementary Figure S3 from A Sequential Targeting Strategy Interrupts AKT-Driven Subclone-Mediated Progression in Glioblastoma
由: Sied Kebir (15048732)
出版: (2025)

Supplementary Figure S4 from A Sequential Targeting Strategy Interrupts AKT-Driven Subclone-Mediated Progression in Glioblastoma
由: Sied Kebir (15048732)
出版: (2025)

Supplementary Tables S1-4 from A Sequential Targeting Strategy Interrupts AKT-Driven Subclone-Mediated Progression in Glioblastoma
由: Sied Kebir (15048732)
出版: (2025)

Figure 1 from DIPG Harbors Alterations Targetable by MEK Inhibitors, with Acquired Resistance Mechanisms Overcome by Combinatorial Inhibition
由: Elisa Izquierdo (15110795)
出版: (2025)

Figure 2 from DIPG Harbors Alterations Targetable by MEK Inhibitors, with Acquired Resistance Mechanisms Overcome by Combinatorial Inhibition
由: Elisa Izquierdo (15110795)
出版: (2025)

Figure 3 from DIPG Harbors Alterations Targetable by MEK Inhibitors, with Acquired Resistance Mechanisms Overcome by Combinatorial Inhibition
由: Elisa Izquierdo (15110795)
出版: (2025)

Figure 4 from DIPG Harbors Alterations Targetable by MEK Inhibitors, with Acquired Resistance Mechanisms Overcome by Combinatorial Inhibition
由: Elisa Izquierdo (15110795)
出版: (2025)

Figure 5 from DIPG Harbors Alterations Targetable by MEK Inhibitors, with Acquired Resistance Mechanisms Overcome by Combinatorial Inhibition
由: Elisa Izquierdo (15110795)
出版: (2025)

Figure 6 from DIPG Harbors Alterations Targetable by MEK Inhibitors, with Acquired Resistance Mechanisms Overcome by Combinatorial Inhibition
由: Elisa Izquierdo (15110795)
出版: (2025)

Figure 7 from DIPG Harbors Alterations Targetable by MEK Inhibitors, with Acquired Resistance Mechanisms Overcome by Combinatorial Inhibition
由: Elisa Izquierdo (15110795)
出版: (2025)

Supplementary Data File 1 from Phase II Investigation of TVB-2640 (Denifanstat) with Bevacizumab in Patients with First Relapse High-Grade Astrocytoma
由: William Kelly (15439117)
出版: (2025)

Supplementary Data File 2 from Phase II Investigation of TVB-2640 (Denifanstat) with Bevacizumab in Patients with First Relapse High-Grade Astrocytoma
由: William Kelly (15439117)
出版: (2025)

Supplementary Table 4 from A Compendium of Syngeneic, Transplantable Pediatric High-Grade Glioma Models Reveals Subtype-Specific Therapeutic Vulnerabilities
由: Michael McNicholas (16447294)
出版: (2025)

Supplementary Table 5 from A Compendium of Syngeneic, Transplantable Pediatric High-Grade Glioma Models Reveals Subtype-Specific Therapeutic Vulnerabilities
由: Michael McNicholas (16447294)
出版: (2025)

Supplementary Table 6 from A Compendium of Syngeneic, Transplantable Pediatric High-Grade Glioma Models Reveals Subtype-Specific Therapeutic Vulnerabilities
由: Michael McNicholas (16447294)
出版: (2025)

Supplementary Table 1 from Somatic Mutations in HLA Class Genes and Antigen-Presenting Molecules in Malignant Glioma
由: Sara C. Schulte (21644540)
出版: (2025)

Supplementary Table 2 from Somatic Mutations in HLA Class Genes and Antigen-Presenting Molecules in Malignant Glioma
由: Sara C. Schulte (21644540)
出版: (2025)

Supplementary Table 3 from Somatic Mutations in HLA Class Genes and Antigen-Presenting Molecules in Malignant Glioma
由: Sara C. Schulte (21644540)
出版: (2025)

Supplementary Figure 1 from Pharmacokinetic Analysis of Carboplatin and Fluorescein Brain Retention following Ultrasound-Based Blood–Brain Barrier Opening
由: Karl J. Habashy (17801087)
出版: (2025)

Supplementary Figure 2 from Pharmacokinetic Analysis of Carboplatin and Fluorescein Brain Retention following Ultrasound-Based Blood–Brain Barrier Opening
由: Karl J. Habashy (17801087)
出版: (2025)